Emerging Markets Propel Takeda's 1Q; R&D Renovation In Full Swing
Executive Summary
Takeda's management spotlighted Axcelead, its recently launched drug services initiative in Japan that aims to bridge the gap between exploratory research and commercial success, during the company's first quarter earnings call.